Description

(R)-5-(3-Chlorophenyl)-3-(1-((4-Methyl-5-(Pyridin-4-Yl)-4H-1,2,4-Triazol-3-Yl)Oxy)Ethyl)Isoxazole is a high-purity, chiral organic compound featuring a complex heterocyclic structure that integrates isoxazole, triazole, and pyridine moieties. This compound is of significant value as a sophisticated pharmaceutical intermediate or research chemical for the development of novel bioactive molecules. It is primarily sought by pharmaceutical R&D organizations, contract research organizations (CROs), and academic research institutions engaged in medicinal chemistry and drug discovery programs.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of potential drug candidates targeting various diseases.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties.
• Chemical Biology Probe: Serves as a tool compound to investigate specific biological pathways or protein functions.
• Agrochemical Research: Potential intermediate in the development of new active ingredients for crop protection.
• Chiral Catalyst or Ligand Precursor: The defined stereochemistry makes it a candidate for developing asymmetric synthesis catalysts.
• Reference Standard: Used for analytical method development and validation in quality control laboratories.

Basic Information

Product Name	(R)-5-(3-Chlorophenyl)-3-(1-((4-Methyl-5-(Pyridin-4-Yl)-4H-1,2,4-Triazol-3-Yl)Oxy)Ethyl)Isoxazole
CAS No.	934282-55-0
Molecular Formula	C19H15ClN4O2
Molecular Weight	366.80 g/mol
Synonyms	(R)-5-(3-Chlorophenyl)-3-[1-([4-methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]oxy)ethyl]isoxazole; (R)-enantiomer of 934282-55-0; 4H-1,2,4-Triazole-3-ol, 4-methyl-5-(4-pyridinyl)-, 1-[(5-(3-chlorophenyl)-3-isoxazolyl)ethyl] ether, (R)-; UNII-8G9K7329VK; (R)-5-(3-Chlorophenyl)-3-(1-((4-methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)oxy)ethyl)isoxazole; (R)-5-(3-Chlorophenyl)-3-(1-{[4-methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]oxy}ethyl)-1,2-oxazole
EINECS	Contact for details

Quality Control

Our production of (R)-5-(3-Chlorophenyl)-3-(1-((4-Methyl-5-(Pyridin-4-Yl)-4H-1,2,4-Triazol-3-Yl)Oxy)Ethyl)Isoxazole adheres to stringent quality protocols to ensure batch-to-batch consistency and high purity. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, chiral purity, and impurity profiles. We employ advanced analytical techniques including HPLC, GC, NMR, and chiral HPLC to verify specifications. Our quality system is designed to meet the exacting standards required for pharmaceutical R&D applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). For long-term storage, consider storing under an inert atmosphere to maintain stability. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Chiral Purity (Chiral HPLC)	≥ 98.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.